196 related articles for article (PubMed ID: 24302581)
1. PPARα activation can help prevent and treat non-small cell lung cancer.
Skrypnyk N; Chen X; Hu W; Su Y; Mont S; Yang S; Gangadhariah M; Wei S; Falck JR; Jat JL; Zent R; Capdevila JH; Pozzi A
Cancer Res; 2014 Jan; 74(2):621-31. PubMed ID: 24302581
[TBL] [Abstract][Full Text] [Related]
2. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Wu L; Wang W; Dai M; Li H; Chen C; Wang D
BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis.
Pozzi A; Ibanez MR; Gatica AE; Yang S; Wei S; Mei S; Falck JR; Capdevila JH
J Biol Chem; 2007 Jun; 282(24):17685-95. PubMed ID: 17405874
[TBL] [Abstract][Full Text] [Related]
4. The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated.
Pozzi A; Popescu V; Yang S; Mei S; Shi M; Puolitaival SM; Caprioli RM; Capdevila JH
J Biol Chem; 2010 Apr; 285(17):12840-50. PubMed ID: 20178979
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
[TBL] [Abstract][Full Text] [Related]
6. The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid Production.
Sausville LN; Gangadhariah MH; Chiusa M; Mei S; Wei S; Zent R; Luther JM; Shuey MM; Capdevila JH; Falck JR; Guengerich FP; Williams SM; Pozzi A
Cancer Res; 2018 Sep; 78(17):4865-4877. PubMed ID: 30012669
[TBL] [Abstract][Full Text] [Related]
7. Targeting 3-phosphoinositide-dependent protein kinase 1 by N-acetyl-cysteine through activation of peroxisome proliferators activated receptor alpha in human lung cancer cells, the role of p53 and p65.
Hann SS; Zheng F; Zhao S
J Exp Clin Cancer Res; 2013 Jul; 32(1):43. PubMed ID: 23867003
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Yu W; Chen L; Yang YQ; Falck JR; Guo AM; Li Y; Yang J
Cancer Chemother Pharmacol; 2011 Sep; 68(3):619-29. PubMed ID: 21120482
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor ɑ (PPARɑ)-cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2- breast cancer.
Tauber Z; Koleckova M; Cizkova K
Med Mol Morphol; 2020 Sep; 53(3):141-148. PubMed ID: 31823010
[TBL] [Abstract][Full Text] [Related]
10. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling.
Chen J; Liu A; Lin Z; Wang B; Chai X; Chen S; Lu W; Zheng M; Cao T; Zhong M; Li R; Wu M; Lu Z; Pang W; Huang W; Xiao L; Lin D; Wang Z; Lei F; Chen X; Long W; Zheng Y; Chen Q; Zeng J; Ren D; Li J; Zhang X; Huang Y
Cancer Lett; 2020 Jul; 482():56-71. PubMed ID: 32289442
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome p450 epoxygenase promotes human cancer metastasis.
Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
[TBL] [Abstract][Full Text] [Related]
13. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.
Zhu YM; Azahri NS; Yu DC; Woll PJ
BMC Cancer; 2008 Jul; 8():218. PubMed ID: 18671849
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
15. Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancer.
Okita R; Maeda A; Shimizu K; Nojima Y; Saisho S; Nakata M
Oncol Rep; 2019 Aug; 42(2):839-848. PubMed ID: 31173242
[TBL] [Abstract][Full Text] [Related]
16. Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
Takahashi O; Komaki R; Smith PD; Jürgensmeier JM; Ryan A; Bekele BN; Wistuba II; Jacoby JJ; Korshunova MV; Biernacka A; Erez B; Hosho K; Herbst RS; O'Reilly MS
Clin Cancer Res; 2012 Mar; 18(6):1641-54. PubMed ID: 22275507
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L
Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205
[TBL] [Abstract][Full Text] [Related]
19. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways.
Pal HC; Sharma S; Strickland LR; Agarwal J; Athar M; Elmets CA; Afaq F
PLoS One; 2013; 8(10):e77270. PubMed ID: 24124611
[TBL] [Abstract][Full Text] [Related]
20. Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer.
Xia HW; Zhang ZQ; Yuan J; Niu QL
Life Sci; 2021 Jan; 265():118768. PubMed ID: 33217443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
